CBSA Presents on Thriving Life Sciences Community to ACE Delegation

Colorado BioScience Association (CBSA) creates co-opportunity for the Colorado life sciences community. Last week, CBSA’s President and CEO Jennifer Jones Paton presented at a session of The ACE 13 ev...

Learn More

Event Series The Leader Within Highlights Inspiring Stories of Leadership

In 2021, Colorado Bioscience Association and the Medtronic Women’s Network teamed up to create The Leader Within – a virtual event series to hear from local life sciences leaders in an exclusive setti...

Learn More

Weekly Policy Update: CBSA Lays Groundwork for Upcoming 2022 Session

Colorado BioScience Association (CBSA) leads Policy + Advocacy efforts to support a collaborative, pro-innovation environment for life sciences in Colorado. We work to advance state and federal polici...

Learn More

A Message from President & CEO Jennifer Jones Paton on her Transition from CBSA

Dear Colorado Life Sciences Community, After almost five years at Colorado BioScience Association and more than two years as President & CEO, I have decided to transition from my role at CBSA to f...

Learn More

Colorado BioScience Association Announces Departure of President & CEO, Jennifer Jones Paton

Board of Directors to Begin Comprehensive Search for Replacement DENVER – Colorado BioScience Association (CBSA) announced Jennifer Jones Paton’s plans to transition from her President & CEO role....

Learn More

Policy + Advocacy: End-of-Session Report

CBSA leads Policy + Advocacy efforts to support a collaborative, pro-innovation environment for life sciences in Colorado. We work to advance state and federal policies that support the companies in o...

Learn More

A Letter from Our President & CEO

Colorado Life Sciences Community: Our ecosystem continues to demonstrate remarkable growth and innovation as we enter the second half of 2021. Medtronic broke ground on a new campus in Lafayette at th...

Learn More

Foresight Diagnostics Transforms Standard of Care for Disease Surveillance

Foresight Diagnostics, an emerging leader in blood-based lymphoma disease monitoring, is transforming patient care with groundbreaking cancer surveillance technology. The Foresight team can identify p...

Learn More

Weekly Policy Update: CBSA Signs BIO CEO Declaration on Global Access to COVID-19 Vaccines and Treatments and the Role of Intellectual Property

Colorado BioScience Association (CBSA) and close to 300 other global biotechnology companies and associations have come together in opposition to waiving IP protections for COVID-19 vaccines and treat...

Learn More

Weekly Policy Update: PASTEUR Act, COVID-19 Intellectual Property, and June Economic Forecast

CBSA Applauds Senator Bennet for Legislation to Ensure Patient Access to Leading-Edge Diagnostics Last week Senator Michael Bennet introduced new bipartisan legislation in the U.S. Senate that would s...

Learn More